Abstract:Background: The published literature regarding the relationships between retinol-binding protein 4 (RBP4) and cardiometabolic risk factors and subclinical atherosclerosis is conflicting, likely due, in part, to limitations of frequently used RBP4 assays. Prior large studies have not utilized the gold-standard western blot analysis of RBP4 levels. Methods: Full-length serum RBP4 levels were measured by western blot in 709 postmenopausal women screened for the Kronos Early Estrogen Prevention Study. Cross-sectional analyses related RBP4 levels to cardiometabolic risk factors, carotid artery intima-media thickness (CIMT), and coronary artery calcification (CAC). Results: The mean age of women was 52.9 (± 2.6) years, and the median RBP4 level was 49.0 (interquartile range 36.9-61.5) μg/mL. Higher RBP4 levels were weakly associated with higher triglycerides (age, race, and smoking-adjusted partial Spearman correlation coefficient = 0.10; P = 0.01), but were unrelated to blood pressure, cholesterol, C-reactive protein, glucose, insulin, and CIMT levels (all partial Spearman correlation coefficients ≤0.06, P > 0.05). Results suggested a curvilinear association between RBP4 levels and CAC, with women in the bottom and upper quartiles of RBP4 having higher odds of CAC (odds ratio [95% confidence interval] 2.10 [1.07-4.09], 2.00 [1.02-3.92], 1.64 [0.82-3.27] for the 1st, 3rd, and 4th RBP4 quartiles vs. the 2nd quartile). However, a squared RBP4 term in regression modeling was non-significant (P = 0.10). Conclusions: In these healthy, recently postmenopausal women, higher RBP4 levels were weakly associated with elevations in triglycerides and with CAC, but not with other risk factors or CIMT. These data using the gold standard of RBP4 methodology only weakly support the possibility that perturbations in RBP4 homeostasis may be an additional risk factor for subclinical coronary atherosclerosis. Trial registration: ClinicalTrials.gov number NCT00154180.

Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.

Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population

Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemia.

Elevated Plasma Retinol-Binding Protein 4 Is Associated With Increased Risk Of Type 2 Diabetes In Middle-Aged And Elderly Chinese Adults

Significance of RBP4 in Patients with Gestational Diabetes Mellitus: a Case-Control Study of Han Chinese Women

Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population

Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study

Associaton of Retinol Binding Protein 4 (RBP4) Levels With Hyperuricemia: A Cross-Sectional Study in a Chinese Population

Sexual Dimorphism in the Association of Serum Retinol-Binding Protein-4 With Long-Term Dynamic Metabolic Profiles in Non-Diabetes

Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study

Association of Serum Retinol-Binding Protein 4 and Visceral Adiposity in Chinese Subjects with and Without Type 2 Diabetes

Serum retinal-binding protein 4 is positively related to insulin resistance in Chinese subjects with type 2 diabetes.

Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A Community-Based Cross-Sectional Study

Serum Retinol-Binding Protein 4 Levels Are Elevated but Do Not Contribute to Insulin Resistance in Newly Diagnosed Chinese Hypertensive Patients

The Relationship Between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus in Chinese Women

Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people.

Elevated RBP4 Plasma Levels Were Associated with Diabetic Retinopathy in Type 2 Diabetes.

Association of Serum Retinol-Binding Protein 4 Levels and the Risk of Incident Type 2 Diabetes in Subjects With Prediabetes.

Serum levels of retinol binding protein 4, adiponectin and tumor necrosis factor-alpha and their correlations in patients with obesity and type 2 diabetes mellitus

Effect of RBP4 Gene Variants on Circulating RBP4 Concentration and Type 2 Diabetes in a Chinese Population

Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study